Jubin P Joseph

Dr. Jubin P Joseph is a Clinical Assistant Professor of Medicine at the Keck School of Medicine of the University of Southern California and serves as Director of Structural Interventions in the Cardiac & Vascular Institute. An interventional cardiologist specializing in structural heart disease, he leads advanced transcatheter valve therapies and clinical research initiatives at USC.

His educational journey includes:

• Undergraduate studies at Cambridge University (2005)
• Medical degree from Oxford University (2008)
• Internal medicine and cardiology training in England
• PhD in invasive physiology research from St Thomas' Hospital, London
• Advanced structural intervention fellowship at Oxford University Hospitals
• Specialized training at Cedars-Sinai Medical Center (2020-2022)

Dr. Joseph's research centers on structural heart disease mechanisms and transcatheter interventions, with particular focus on valve pathophysiology, hemodynamic assessments, and device innovation. His clinical expertise spans transcatheter aortic/mitral/tricuspid valve replacements, MitraClip procedures, left atrial appendage occlusion, and congenital defect closures. He integrates cardiovascular physiology with structural interventions to optimize patient outcomes in complex valve disease.

His publication record reveals consistent advancement in transcatheter valve therapy, emphasizing hemodynamic outcomes, imaging guidance, and novel device applications. Recent work demonstrates leadership in TAVR optimization, mitral repair techniques, and physiological assessment during interventions, reflecting his dual commitment to clinical innovation and scientific rigor.

Major recognitions include:

• Peel and Rothwell Jackson Postgraduate Fellowship (2020-2021)
• European Society of Cardiology's Cardiologist of Tomorrow (2014-2017)
• Royal College of Surgeons' Preiskel Prize (2008)
• Multiple medical education travel awards (2008)
• Cambridge University's Preparing for Patients Prize (2003)

As a clinical investigator, Dr. Joseph actively contributes to national multicenter trials while directing structural interventions at USC's Cardiac & Vascular Institute. His team pioneers emerging transcatheter therapies through rigorous physiological assessment and device evaluation, with ongoing research in microvascular dysfunction and next-generation valve technologies.

The structural interventions program under his leadership focuses on complex valve disease management, combining cutting-edge transcatheter approaches with comprehensive physiological evaluation to advance structural heart care.